Fluorobenzene

We are Fluorobenzene CAS:462-06-6 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

CAS No: 462-06-6
Product Name: Fluorobenzene
Other Name:
Fluorobenzene
Monofluorobenzene
Monofluoro boroxine
4-Fluorobenzene
Monofluorboroxin
 
Density: 1.0±0.1 g/cm3
Boiling Point: 84.7±9.0 °C at 760 mmHg
Melting Point: -42 °C
Molecular Formula: C6H5F
Molecular Weight: 96.102
Flash Point: -12.8±0.0 °C
Exact Mass: 96.037529
LogP: 2.27
Vapour density: 3.31 (vs air)
Vapour Pressure: 79.9±0.1 mmHg at 25°C
Index of Refraction: 1.473
Stability: Stable. Incompatible with oxidizing agents. Highly flammable – note low flash point.
Water Solubility: INSOLUBLE
 
Specification
Appearance: Colorless liquid
Assay: ≥98.0%
Water: ≤0.50%
 
Application
It is mainly used for the main anti-psychotic drugs such as fluorobutanol, darofene benzene, trifluoropiperidine, trifluoropiperidine benzene, penfluridol and quinolone-ciprofloxacin.
It is also used for the identification of pesticides and ovicides and plastics and resin polymers.
The condensation of fluorobenzene with γ-chlorobutyryl chloride can produce γ-chloro-p-fluorobutanone, which is used in the synthesis of haloperidol, and is the most commonly used drug for butyrophenone antipsychotics.
Applicationd as insecticide, ovicide, and for the identification of plastics and resin polymers.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

Fluorobenzene


Related News: In an August overhaul to its drug administration law, Beijing said conditional approval could be granted to some still-under-research medicines of “predictable” clinical value for life-threatening diseases for which effective treatment is not immediately available.49660-57-3 The intravenous form of rigosertib has been studied in Phase 1, 2, and 3 clinical trials involving more than 1000 patients, and is currently being evaluated in a randomized Phase 3 international INSPIRE trial for patients with HR-MDS after failure of HMA therapy.3-Chloro-6-(trifluoromethyl)pyridazine The intravenous form of rigosertib has been studied in Phase 1, 2, and 3 clinical trials involving more than 1000 patients, and is currently being evaluated in a randomized Phase 3 international INSPIRE trial for patients with HR-MDS after failure of HMA therapy.4-Fluoro-3-methylbenzaldehyde CAS:135427-08-6 The complete chemical and pharmaceutical industry chain consists of basic chemical raw materials, pharmaceutical intermediates, chemical raw materials and chemical preparations.Especially tumor drugs with selective targeting characteristics. At present, about 80% of small drug (high-efficiency drug) APIs worldwide are patented drugs.

Related Products
Product Name
6-(Trifluoromethyl)indoline View Details
Methyltriethoxysilane View Details
(R,E)-ethyl 5-([1,1′-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpent-2-enoate View Details
2-Fluoro-3-methylbenzoic acid manufacturer cuminaldehyde manufacturer 6-Amino-5-bromoquinoxaline manufacturer 2-Fluorotoluene manufacturer epolamine manufacturer